People assigned female at birth have adverse reactions to drugs almost twice as often as their male counterparts.
“I couldn’t even get cough syrup for my baby ... and I sell the drugs.”
This week in science: genetically modified, drug-producing chickens, the health benefits of being a morning person, and using artificial intelligence to read minds.
Barry and Honey Sherman were found dead last December after being strangled in their Toronto mansion.
Inside the world of clandestine chemists and the DIY bio-hackers trying to disrupt the pharmaceutical industry.
The announcement comes after a report suggested Barry and Honey Sherman's deaths were the result of a professional hit.
The man who rose to fame for hiking the price of Daraprim was arrested by the FBI after an investigation involving his former hedge fund and a pharmaceutical company he previously headed.
The pharmaceutical exec who increased the price of a drug used to treat AIDS more than 55-fold overnight continues his four month run of news-grabbing form.
Connecticut-based Alexion Pharmaceuticals has submitted a motion to Canada’s Federal Court alleging the government has no authority over the cost of Soliris, which treats two rare blood diseases.
An expert told us there "a gold rush for profit" in patent-centric areas such as the drug biz.
They may be the second-smallest country in the talks, but Kiwis are up in arms over the rampant secrecy surrounding the deal.